We are live on ! Find out more
NC

NinePointTwo Capital Portfolio holdings

AUM $252M
1-Year Est. Return 12.98%
This Fund
S&P 500
This Quarter Est. Return
-0.43%
1 Year Est. Return
+12.98%
3 Year Est. Return
+1.62%
5 Year Est. Return
10 Year Est. Return
AUM
$258M
AUM Growth
-$25.8M
Cap. Flow
-$23.2M
Cap. Flow %
-8.99%
Top 10 Hldgs %
87.34%
Holding
97
New
28
Increased
4
Reduced
4
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 4.81%
2 Healthcare 2.84%
3 Communication Services 2.01%
4 Financials 1.79%
5 Consumer Discretionary 1.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INVA icon
51
Innoviva
INVA
$1.58B
$185K 0.07%
+11,123
New +$166K
EMKR
52
DELISTED
Emcore Corp
EMKR
$181K 0.07%
+2,420
New +$193K
NSLR
53
Neostellar Capital Corp
NSLR
$262M
$175K 0.07%
+13,604
New +$179K
TRUE
54
DELISTED
TrueCar
TRUE
$173K 0.07%
+41,760
New +$194K
BNFT
55
DELISTED
Benefitfocus, Inc.
BNFT
$172K 0.07%
+15,519
New +$189K
BRMK
56
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$151K 0.06%
+15,322
New +$159K
MFIC icon
57
MidCap Financial Investment
MFIC
$784M
$149K 0.06%
+11,561
New +$157K
PSEC icon
58
Prospect Capital
PSEC
$1.06B
$149K 0.06%
+19,462
New +$157K
DNOW icon
59
DNOW Inc
DNOW
$2.63B
$142K 0.06%
+18,579
New +$152K
NUVB icon
60
Nuvation Bio
NUVB
$2.24B
$140K 0.05%
+14,115
New +$128K
TDAY
61
USA Today Co
TDAY
$1.23B
$139K 0.05%
+20,936
New +$123K
DBD
62
DELISTED
Diebold Nixdorf Incorporated
DBD
$139K 0.05%
+13,802
New +$151K
PRVB
63
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$134K 0.05%
+21,077
New +$135K
ZIXI
64
DELISTED
Zix Corporation
ZIXI
$134K 0.05%
+19,046
New +$137K
KNDI
65
Kandi Technologies Group
KNDI
$65.3M
$131K 0.05%
+29,517
New +$149K
BCOV
66
DELISTED
Brightcove, Inc.
BCOV
$127K 0.05%
+11,076
New +$134K
CRON
67
Cronos Group
CRON
$1.05B
$125K 0.05%
22,246
+10,922
+96% +$74.2K
SURF
68
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$122K 0.05%
+16,206
New +$104K
CHS
69
DELISTED
Chicos FAS, Inc.
CHS
$107K 0.04%
+24,047
New +$137K
TWI icon
70
Titan International
TWI
$516M
$102K 0.04%
+14,257
New +$113K
BW icon
71
Babcock & Wilcox
BW
$1.43B
$101K 0.04%
+15,895
New +$111K
TALK icon
72
Talkspace
TALK
$873M
$99K 0.04%
+27,274
New +$150K
EOLS icon
73
Evolus
EOLS
$394M
$92K 0.04%
+12,140
New +$126K
ENBL
74
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$92K 0.04%
+11,387
New +$93K
IMVT icon
75
Immunovant
IMVT
$8.09B
$88K 0.03%
+10,168
New +$91.7K

Similar funds

NinePointTwo Capital's Q3 2021 Portfolio in Review

As of Q3 2021, NinePointTwo Capital held 97 positions worth $258M, down 9.1% from $284M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

NinePointTwo Capital withdrew a net $23.2M in Q3 2021, closing 16 positions and reducing 4 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $15M position sold in full.

By sector, the portfolio is most concentrated in Technology at 4.8% of assets, up from 4.3% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, NinePointTwo Capital opened a new position in Forte Biosciences worth $54K.

  • NinePointTwo Capital's largest Q3 2021 buy was Forte Biosciences: 739 shares worth $54K.
  • NinePointTwo Capital added most to Schwab US TIPS ETF in Q3 2021, an estimated $36.2M increase.
  • NinePointTwo Capital's biggest Q3 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $14.4M.
  • NinePointTwo Capital fully exited iShares Core S&P 500 ETF in Q3 2021, selling an estimated $15M.
  • NinePointTwo Capital's ten largest holdings make up 87% of its $258M portfolio in Q3 2021.
  • NinePointTwo Capital opened 28 new positions and closed 16 in Q3 2021.
  • NinePointTwo Capital's portfolio value fell 9.1% quarter-over-quarter to $258M.

Based on NinePointTwo Capital's 13F filing for Q3 2021, filed 10 Nov 2021.